Radiopharm Theranostics Balance Sheet Health
Financial Health criteria checks 4/6
Radiopharm Theranostics has a total shareholder equity of A$24.3M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$63.3M and A$38.9M respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
Interest coverage ratio | n/a |
Cash | AU$1.89m |
Equity | AU$24.34m |
Total liabilities | AU$38.95m |
Total assets | AU$63.29m |
Financial Position Analysis
Short Term Liabilities: RAD's short term assets (A$6.5M) do not cover its short term liabilities (A$12.8M).
Long Term Liabilities: RAD's short term assets (A$6.5M) do not cover its long term liabilities (A$26.1M).
Debt to Equity History and Analysis
Debt Level: RAD is debt free.
Reducing Debt: RAD had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RAD has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: RAD is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.